Adicet Bio Inc (ACET)

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Adicet Bio to Participate in Fireside Chat at Jefferies Global Healthcare Conference

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for...

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Adicet Bio Reports First Quarter 2026 Financial Results and Provides Business Updates

Clinical update anticipated in mid-2026 for Phase 1 autoimmune program evaluating prulacabtagene leucel (prula-cel, formerly ADI-001) with at...

Form ARS - Annual Report to Security Holders

Form 8-K - Current report